Arcellx Inc.

54.98+2.45+4.66%Vol 632.49K1Y Perf 166.65%
Dec 1st, 2023 16:00 DELAYED
BID51.83 ASK57.26
Open52.60 Previous Close52.53
Pre-Market- After-Market54.98
 - -  - -%
Target Price
35.83 
Analyst Rating
Strong Buy 1.08
Potential %
-34.83 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
97.03 
Earnings Rating
Market Cap2.68B 
Earnings Date
13th Nov 2023
Alpha0.05 Standard Deviation0.23
Beta-0.56 

Today's Price Range

51.1955.18

52W Range

18.7056.09

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
3.19%
1 Month
34.85%
3 Months
47.01%
6 Months
30.94%
1 Year
166.65%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ACLX54.982.45004.66
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
6.30
6.50
0.19
0.37
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-
-
-
-
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.68-0.5026.47
Q01 20232.52-0.58-123.02
Q04 2022-0.71-0.76-7.04
Q03 2022-0.93-0.6826.88
Q02 2022-1.20-0.8826.67
Q01 2022-0.95-1.56-64.21
Q04 2021-0.69-39.85-5 675.36
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.56
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume632.49K
Shares Outstanding48.69K
Shares Float31.87M
Trades Count11.17K
Dollar Volume34.20M
Avg. Volume681.62K
Avg. Weekly Volume567.03K
Avg. Monthly Volume896.33K
Avg. Quarterly Volume581.50K

Arcellx Inc. (NASDAQ: ACLX) stock closed at 54.98 per share at the end of the most recent trading day (a 4.66% change compared to the prior day closing price) with a volume of 632.49K shares and market capitalization of 2.68B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 78 people. Arcellx Inc. CEO is .

The one-year performance of Arcellx Inc. stock is 166.65%, while year-to-date (YTD) performance is 77.47%. ACLX stock has a five-year performance of %. Its 52-week range is between 18.7 and 56.09, which gives ACLX stock a 52-week price range ratio of 97.03%

Arcellx Inc. currently has a PE ratio of -8.20, a price-to-book (PB) ratio of 6.23, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -70.65%, a ROC of -111.26% and a ROE of -257.16%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Arcellx Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.56 for the next earnings report. Arcellx Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Arcellx Inc. is Strong Buy (1.08), with a target price of $35.83, which is -34.83% compared to the current price. The earnings rating for Arcellx Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Arcellx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Arcellx Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 68.42, ATR14 : 3.18, CCI20 : 77.52, Chaikin Money Flow : 0.17, MACD : 4.04, Money Flow Index : 65.68, ROC : 20.84, RSI : 69.29, STOCH (14,3) : 91.18, STOCH RSI : 0.83, UO : 61.35, Williams %R : -8.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Arcellx Inc. in the last 12-months were: Christopher Heery (Option Excercise at a value of $654 080), Christopher Heery (Sold 70 863 shares of value $2 456 596 ), Rami Elghandour (Option Excercise at a value of $0), Rami Elghandour (Sold 31 442 shares of value $967 423 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
12 (92.31 %)
11 (91.67 %)
9 (90.00 %)
Moderate Buy
1 (7.69 %)
1 (8.33 %)
1 (10.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.08
Strong Buy
1.08
Strong Buy
1.10

Arcellx Inc.

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

CEO:

Telephone: +1 240 327-0603

Address: 25 West Watkins Mill Road, Gaithersburg 20878, MD, US

Number of employees: 78

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

60%40%

 

News

Stocktwits